Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
ALLERGEN EXTRACT VACCINES is a federal award for W40m Mrco East held by Greer Laboratories, Inc. Estimated value $261K ($261K obligated). Current period of performance ends Sep 1, 2023. Place of performance: FORT GEORGE G MEADE MD.
Recompete timing
PublicCurrent PoP ended Sep 1, 2023 (1085 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W91YTZ23F0186?
W91YTZ23F0186 (Allergen extract vaccines) is a W40m Mrco East award with a potential value of $261K, currently held by Greer Laboratories, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W91YTZ-23-F-0186?
W91YTZ-23-F-0186 is the dashed form of PIID W91YTZ23F0186 (Allergen extract vaccines), held by Greer Laboratories, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W91YTZ23F0186?
W40m Mrco East awarded W91YTZ23F0186 to Greer Laboratories, Inc (potential $261K).
Who is the incumbent on W91YTZ23F0186?
Greer Laboratories, Inc is the incumbent. The current period of performance ends Sep 1, 2023.
When does Greer Laboratories, Inc’s W91YTZ23F0186 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 1, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.